Heterogeneity of large cell carcinoma of the lung

An immunophenotypic and miRNA-based analysis

Mattia Barbareschi, Chiara Cantaloni, Valerio Del Vescovo, Alberto Cavazza, Valentina Monica, Rodolfo Carella, Giulio Rossi, Luca Morelli, Alberto Cucino, Massimo Silvestri, Giuseppe Tirone, Giuseppe Pelosi, Paolo Graziano, Mauro Papotti, Paolo Dalla Palma, Claudio Doglioni, Michela Alessandra Denti

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34%) of the cases were reclassified as ADC and 14 (25%) as SQCC; 23 (41%) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60% of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation.

Original languageEnglish
Pages (from-to)773-782
Number of pages10
JournalAmerican Journal of Clinical Pathology
Volume136
Issue number5
DOIs
Publication statusPublished - Nov 2011

Fingerprint

Large Cell Carcinoma
MicroRNAs
Squamous Cell Carcinoma
Adenocarcinoma
Lung
Desmocollins
Keratin-5
Keratin-7
Cell Lineage
Neoplasms

Keywords

  • Adenocarcinoma
  • Heterogeneity
  • Immunophenotype
  • Large cell carcinoma
  • Lung neoplasms
  • miRNA
  • Squamous cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Heterogeneity of large cell carcinoma of the lung : An immunophenotypic and miRNA-based analysis. / Barbareschi, Mattia; Cantaloni, Chiara; Vescovo, Valerio Del; Cavazza, Alberto; Monica, Valentina; Carella, Rodolfo; Rossi, Giulio; Morelli, Luca; Cucino, Alberto; Silvestri, Massimo; Tirone, Giuseppe; Pelosi, Giuseppe; Graziano, Paolo; Papotti, Mauro; Palma, Paolo Dalla; Doglioni, Claudio; Denti, Michela Alessandra.

In: American Journal of Clinical Pathology, Vol. 136, No. 5, 11.2011, p. 773-782.

Research output: Contribution to journalArticle

Barbareschi, M, Cantaloni, C, Vescovo, VD, Cavazza, A, Monica, V, Carella, R, Rossi, G, Morelli, L, Cucino, A, Silvestri, M, Tirone, G, Pelosi, G, Graziano, P, Papotti, M, Palma, PD, Doglioni, C & Denti, MA 2011, 'Heterogeneity of large cell carcinoma of the lung: An immunophenotypic and miRNA-based analysis', American Journal of Clinical Pathology, vol. 136, no. 5, pp. 773-782. https://doi.org/10.1309/AJCPYY79XAGRAYCJ
Barbareschi, Mattia ; Cantaloni, Chiara ; Vescovo, Valerio Del ; Cavazza, Alberto ; Monica, Valentina ; Carella, Rodolfo ; Rossi, Giulio ; Morelli, Luca ; Cucino, Alberto ; Silvestri, Massimo ; Tirone, Giuseppe ; Pelosi, Giuseppe ; Graziano, Paolo ; Papotti, Mauro ; Palma, Paolo Dalla ; Doglioni, Claudio ; Denti, Michela Alessandra. / Heterogeneity of large cell carcinoma of the lung : An immunophenotypic and miRNA-based analysis. In: American Journal of Clinical Pathology. 2011 ; Vol. 136, No. 5. pp. 773-782.
@article{8e8e1dc16c2945c88901768ff70cda85,
title = "Heterogeneity of large cell carcinoma of the lung: An immunophenotypic and miRNA-based analysis",
abstract = "Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34{\%}) of the cases were reclassified as ADC and 14 (25{\%}) as SQCC; 23 (41{\%}) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60{\%} of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation.",
keywords = "Adenocarcinoma, Heterogeneity, Immunophenotype, Large cell carcinoma, Lung neoplasms, miRNA, Squamous cell carcinoma",
author = "Mattia Barbareschi and Chiara Cantaloni and Vescovo, {Valerio Del} and Alberto Cavazza and Valentina Monica and Rodolfo Carella and Giulio Rossi and Luca Morelli and Alberto Cucino and Massimo Silvestri and Giuseppe Tirone and Giuseppe Pelosi and Paolo Graziano and Mauro Papotti and Palma, {Paolo Dalla} and Claudio Doglioni and Denti, {Michela Alessandra}",
year = "2011",
month = "11",
doi = "10.1309/AJCPYY79XAGRAYCJ",
language = "English",
volume = "136",
pages = "773--782",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "5",

}

TY - JOUR

T1 - Heterogeneity of large cell carcinoma of the lung

T2 - An immunophenotypic and miRNA-based analysis

AU - Barbareschi, Mattia

AU - Cantaloni, Chiara

AU - Vescovo, Valerio Del

AU - Cavazza, Alberto

AU - Monica, Valentina

AU - Carella, Rodolfo

AU - Rossi, Giulio

AU - Morelli, Luca

AU - Cucino, Alberto

AU - Silvestri, Massimo

AU - Tirone, Giuseppe

AU - Pelosi, Giuseppe

AU - Graziano, Paolo

AU - Papotti, Mauro

AU - Palma, Paolo Dalla

AU - Doglioni, Claudio

AU - Denti, Michela Alessandra

PY - 2011/11

Y1 - 2011/11

N2 - Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34%) of the cases were reclassified as ADC and 14 (25%) as SQCC; 23 (41%) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60% of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation.

AB - Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34%) of the cases were reclassified as ADC and 14 (25%) as SQCC; 23 (41%) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60% of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation.

KW - Adenocarcinoma

KW - Heterogeneity

KW - Immunophenotype

KW - Large cell carcinoma

KW - Lung neoplasms

KW - miRNA

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=80355129921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80355129921&partnerID=8YFLogxK

U2 - 10.1309/AJCPYY79XAGRAYCJ

DO - 10.1309/AJCPYY79XAGRAYCJ

M3 - Article

VL - 136

SP - 773

EP - 782

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 5

ER -